red meat intake, alcohol, Asprine Incidence, rectal use, education, 257/ per 1 score 1.07 (0.94-1.22) cancer family history of colorectal cancer, smoking Age, cigarette smoking, family KNHIC, history of Prospective cancer, fasting Shin, 2014 Cancer registry Height and Incidence, Used in HvL Cohort, 9 084/ 25 vs 25 blood sugar, ≥ ≤ COL41023 & Insurance weight were colorectal 1.13 (1.07-1.19) analysis, only 2 Age: 30-80 1 326 058 kg/m2 height, alcohol, system measured cancer, male categories years, meat M/W consumption, serum cholesterol No specific Incidence, 1.28 (1.10-1.50) Age, aspirin, Q5 vs Q1 ranges of colorectal cancer Ptrend:0.001 diabetes, family quintiles WHI history of 1.60 (1.26-2.03) Ever used HRT Q5 vs Q1 Prospective Self-report Weight and cancer, HRT Ptrend:<0.001 No number of Kabat, 2015 Cohort, 1 908/ verified by height were use, met-hours cases in each used HRT Q2 vs Q2 1.10 (0.90-1.36) COL41034 Age: 50-79 143 901 medical record measured by per week, quintile USA W, 13 years and pathology trained staff at treatment postmenopausal report baseline allocation, waist 1.25 (1.02-1.54) women circumference, Never used HRT Q5 vs Q1 Kabat, 2013 Ptrend:< 0.01 alcohol, Col40965 used education, instead
red meat intake, alcohol, Asprine use, education, family history of colorectal cancer, smoking 257/ Incidence, rectal cancer per 1 score 1.07 (0.94-1.22) Shin, 2014 COL41023 KNHIC, Prospective Cohort, Age: 30-80 years, M/W 9 084/ 1 326 058 Cancer registry & Insurance system Height and weight were measured Incidence, colorectal cancer, male ≥ 25 vs ≤ 25 kg/m2 1.13 (1.07-1.19) Age, cigarette smoking, family history of cancer, fasting blood sugar, height, alcohol, meat consumption, serum cholesterol Used in HvL analysis, only 2 categories Kabat, 2015 COL41034 USA WHI Prospective Cohort, Age: 50-79 W, postmenopausal women 1 908/ 143 901 13 years Self-report verified by medical record and pathology report Weight and height were measured by trained staff at baseline Incidence, colorectal cancer Q5 vs Q1 1.28 (1.10-1.50) Ptrend:0.001 Age, aspirin, diabetes, family history of cancer, HRT use, met-hours per week, treatment allocation, waist circumference, alcohol, education, No specific ranges of quintiles No number of cases in each quintile Kabat, 2013 Col40965 used instead Ever used HRT Q5 vs Q1 1.60 (1.26-2.03) Ptrend:<0.001 used HRT Q2 vs Q2 1.10 (0.90-1.36) Never used HRT Q5 vs Q1 1.25 (1.02-1.54) Ptrend:< 0.01
CUP_colorectal_SLR_2016_RO.docx